Quantum BioPharma (QNTM) said Tuesday that a trial of its dietary supplement, Unbuzzd, confirmed it accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, and reduces symptoms of intoxication, impairment, and hangover.
The study, which examined Unbuzzd's impact on alcohol intoxication and metabolism, found the results to be statistically significant compared to a placebo.
The effects were noticeable within 30 minutes of consuming the dissolved powder. The supplement was well-tolerated, with no reported adverse effects.
The shares of Quantum BioPharma surged nearly 53% in recent trading.
Price: 4.86, Change: +1.68, Percent Change: +52.83
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。